3 Psychedelic Stocks to Buy on the Dip: Summer 2024

While the cannabis industry has all but become legitimate in the United States, it’s not the only form of alternative medicine attempting to break through regulatory barriers. Compounds like psilocybin, lysergic acid and ketamine are all referred to as psychedelics, yet they may have medical applications which are just beginning to be explored.As such, several newly minted public companies have begun experimenting with ways to harness the therapeutic potential of these compounds. When these companies first ...